CellSource Co., Ltd.
4880.T · JPX
10/31/2025 | 10/31/2024 | 10/31/2023 | 10/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥10,006,060 | ¥23,504,980 | ¥33,670,513 | ¥82,020,892 |
| - Cash | ¥4,711,820 | ¥4,320,915 | ¥4,781,022 | ¥3,123,580 |
| + Debt | ¥56,719 | ¥77,290 | ¥97,542 | ¥0 |
| Enterprise Value | ¥5,350,959 | ¥19,261,355 | ¥28,987,033 | ¥78,897,312 |
| Revenue | ¥3,711,455 | ¥4,355,063 | ¥4,510,544 | ¥4,273,829 |
| % Growth | -14.8% | -3.4% | 5.5% | – |
| Gross Profit | ¥2,087,477 | ¥2,417,412 | ¥3,184,544 | ¥3,064,301 |
| % Margin | 56.2% | 55.5% | 70.6% | 71.7% |
| EBITDA | ¥315,480 | ¥449,530 | ¥1,306,440 | ¥1,644,798 |
| % Margin | 8.5% | 10.3% | 29% | 38.5% |
| Net Income | ¥10,659 | ¥237,940 | ¥923,142 | ¥1,017,842 |
| % Margin | 0.3% | 5.5% | 20.5% | 23.8% |
| EPS Diluted | 0.54 | 11.96 | 47.93 | 52.98 |
| % Growth | -95.5% | -75% | -9.5% | – |
| Operating Cash Flow | ¥333,095 | ¥591,723 | ¥846,691 | ¥847,603 |
| Capital Expenditures | -¥43,190 | -¥539,687 | -¥359,002 | -¥99,167 |
| Free Cash Flow | ¥289,905 | ¥52,036 | ¥487,689 | ¥748,436 |